Quark Pharmaceuticals Raises $10M
Fremont-based Quark Pharmaceuticals, a developer of RNAi-based therapeutic products, announced Thursday that it has raised $10M in a funding round. The round came from Japanese firm SBI Holdings Group. As part of the funding, Quark said it has added Yoshitaka Kitao and Robert Takeuchi, both of SBI, to its board. Quark's lead candidates are a treatment for wet age-related macular degeneration (AMD) and diabetic macular edema (DME).
posted on Thursday, June 10, 2010 (Link to more information)
Related companies:
Quark
Related stories:
> Quark Pharmaceuticals Drops IPO Plans
> Quark Pharmaceuticals Gets $27M
> Quark Biotech Files For IPO
> Pressrun Acquired By Quark
> Bridge Pharmaceuticals Raises $35M
silicontap.com Home